Legacy Bridge’s AbbVie ABBV Stock Holding History

Legacy Bridge’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.54K	Sell	26 -130	-83%	-$28K	﹤0.01%	286
2026 Q1	$33.9K	Hold	156	–	–	0.01%	220
2025 Q4	$35.6K	Buy	156 +152	+3,800%	+$34.6K	0.01%	216
2025 Q3	$927	Hold	4	–	–	﹤0.01%	303
2025 Q2	$743	Buy	+4	New	+$743	﹤0.01%	290
2023 Q1	–	Sell	-472	Closed	-$76.3K	–	296
2022 Q4	$76.3K	Buy	+472	New	+$72.4K	0.05%	179
2022 Q2	–	Sell	-10,222	Closed	-$1.66M	–	290
2022 Q1	$1.66M	Hold	10,222	–	–	0.97%	21
2021 Q4	$1.38M	Buy	10,222 +30	+0.3%	+$3.54K	0.72%	48
2021 Q3	$1.1M	Buy	10,192 +20	+0.2%	+$2.29K	0.63%	71
2021 Q2	$1.15M	Buy	10,172 +425	+4%	+$47.9K	0.65%	68
2021 Q1	$1.05M	Buy	9,747 +816	+9%	+$87.3K	0.68%	65
2020 Q4	$957K	Buy	8,931 +1,390	+18%	+$134K	0.69%	58
2020 Q3	$661K	Sell	7,541 -19	-0.3%	-$1.79K	0.6%	62
2020 Q2	$742K	Sell	7,560 -436	-5%	-$38.4K	0.82%	41
2020 Q1	$609K	Buy	7,996 +699	+10%	+$59.5K	0.77%	43
2019 Q4	$646K	Sell	7,297 -1,414	-16%	-$117K	0.54%	68
2019 Q3	$660K	Sell	8,711 -620	-7%	-$42.5K	0.63%	60
2019 Q2	$679K	Hold	9,331	–	–	0.65%	54
2019 Q1	$752K	Hold	9,331	–	–	0.78%	37
2018 Q4	$860K	Buy	+9,331	New	+$821K	1.06%	16

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legacy Bridge's ABBV Position: Q2 2026 in Review

Legacy Bridge reduced its AbbVie (ABBV) stake by 83% in Q2 2026, selling an estimated $28K and leaving 26 shares worth $6.54K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

Legacy Bridge first reported a position in ABBV in Q4 2018 and has held it in 20 quarters since. The position peaked at $1.66M in Q1 2022. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Legacy Bridge held 26 shares of AbbVie worth $6.54K as of Q2 2026.
Legacy Bridge sold 130 AbbVie shares in Q2 2026, an estimated $28K.
AbbVie made up ﹤0.01% of Legacy Bridge's portfolio in Q2 2026, its #286 holding.
Legacy Bridge first reported a position in AbbVie in Q4 2018 and has held it in 20 quarters since.
Legacy Bridge's AbbVie position peaked at $1.66M in Q1 2022.
4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legacy Bridge's 13F filing for Q2 2026, filed 13 Aug 2026.